Diabetes complications

Association of hemoglobin A1c (A1c) stability with mortality and diabetes complications in older adults with diabetes

BMJ Open Diabetes Res CarePublished Retrospective cohort study

Authors' conclusion

In older adults with diabetes, mortality and macrovascular complications are associated with increased time above and below individualized A1c target ranges. Higher A1c TIR may identify patients with lower risk of adverse outcomes.

Study context

Population
Veterans with diabetes and ≥4 A1c tests during a 3-year baseline, 2004–2016; mean age 76.9 years (SD 5.7)
Participants
397,634 veterans
Exposure
A1c time below, above or mixed vs ≥60% time in individualised target range
Outcome
Mortality, macrovascular and microvascular complications
Follow-up
Average 5.5 years
Methodological detailsobservational
  • Observational

Main finding

As reported in the abstract

Mortality
Each group vs ≥60% TIRHazard ratio (95% CI)
≥60% TBR
1.12(1.11–1.14)
≥60% TAR
1.10(1.08–1.12)
Mixed
1.06(1.04–1.07)

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Microvascular complications≥60% TBRvs ≥60% TIR0.97 (0.95–1.00)
Microvascular complications≥60% TARvs ≥60% TIR1.11 (1.08–1.14)
OutcomeEstimate
Macrovascular complications≥60% TBR vs ≥60% TIR1.04 (95% CI 1.01–1.06)
Macrovascular complications≥60% TAR vs ≥60% TIR1.06 (95% CI 1.03–1.09)

Sensitivity analyses

Results similar with higher time in range (TIR) thresholds, shorter follow-up and competing risk of mortality

Original publication

Association of hemoglobin A1c stability with mortality and diabetes complications in older adults with diabetes. BMJ Open Diabetes Res Care. Published 6 April 2023. doi:10.1136/bmjdrc-2022-003211

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.